高盛：恒瑞医药-2025 年美国ADA会议-GLP - 1 产品组合数据令人鼓舞；预计 2026 年首次推出

16 June 2025 | 3:19PM HKT Hengrui Medicine (600276.SS): ADA 2025: Encouraging data sets from GLP-1 portfolio; Expect initial launch in 2026 On June 13, abstracts from the American Diabetes Association's 85th Scientific Sessions (ADA 2025, June 20-23) have been released. Among China players with data updated for GLP-1 related assets, we highlighted Hengrui with fresh data points for both oral tablet and injection formulation of HRS9531 (GLP-1/GIP), for which the ex-China rights have been licensed-out to a Ne ...